Association of Classic Cardiovascular Risk Factors and Lifestyles With the Cardio-ankle Vascular Index in a General

Marc Elosua-Bayés1, Ruth Martí-Lluch2, María Del Mar García-Gil3

  • 1Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain.

Insights

The cardio-ankle vascular index (CAVI) increases with age and is higher in men, correlating with cardiovascular risk factors. Higher CAVI is linked to hypertension, diabetes, and obesity, suggesting its potential as a predictive biomarker.

Area of Science:

  • Cardiovascular Health
  • Vascular Biology
  • Biomarker Research

Background:

  • Arterial stiffness is a key indicator of cardiovascular health.
  • The cardio-ankle vascular index (CAVI) is a measure of arterial stiffness.
  • Understanding CAVI distribution in diverse populations is crucial for risk assessment.

Purpose of the Study:

  • To describe CAVI distribution in a Mediterranean population.
  • To determine CAVI prevalence by sex and coronary risk.
  • To assess CAVI associations with cardiovascular risk factors and lifestyle.

Main Methods:

  • Cross-sectional study in Girona province, Spain.
  • CAVI measured using the VaSera VS-1500 device.
  • Analysis included 2613 adult participants.

Main Results:

  • Prevalence of CAVI ≥ 9 was 46.8% in men and 36.0% in women.
  • CAVI increased with age and coronary risk level in both sexes.
  • CAVI ≥ 9 associated with hypertension, diabetes, and BMI in men; hypertension, hypercholesterolemia, and obesity in women.

Conclusions:

  • CAVI increases with age and is higher in men.
  • CAVI is associated with traditional cardiovascular risk factors and coronary risk.
  • CAVI shows potential as a cardiovascular risk stratification biomarker, warranting further research.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
938
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
472
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
590